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ABSTRACT 
A new family of block ionomer complexes (BIC) formed by poly(ethylene 
glycol)-block-poly(4-vinylbenzylphosphonate) (PEG-b-PVBP) and various cationic surfactants was 
prepared and characterized. These complexes spontaneously self-assembled in aqueous solutions into 
particles with average size of 40 - 60 nm and remained soluble over the entire range of the compositions 
2 
 
of the mixtures including stoichiometric electroneutral complexes. Solution behavior and 
physicochemical properties of such BIC were very sensitive to the structure of cationic surfactants. 
Furthermore, such complexation was used for incorporation of cationic anti-cancer drug, doxorubicin 
(DOX), into the core of BIC with high loading capacity and efficiency. The DOX/PEG-b-PVBP BIC 
also displayed high stability against dilution, changes in ionic strength. Furthermore, DOX release at the 
extracellular pH of DOX/PEG-b-PVBP BIC was slow. It was greatly increased at the acidic pH 
mimicking the endosomal/lysosomal environment. Confocal fluorescence microscopy using live 
MCF-7 breast cancer cells suggested that DOX/PEG-b-PVBP BICs are transported to lysosomes. 
Subsequently, the drugs are released and exert cytotoxic effect killing these cancer cells. These findings 
indicate that the obtained complexes can be attractive candidates for delivery of cationic drugs to 
tumors. 
 
INTRODUCTION 
A very special class of drug delivery systems based on block and graft copolymers containing 
ionic and non-ionic water-soluble segments (“block ionomers”) was proposed in mid-90-ies [1-4]. Such 
drug delivery systems are spontaneously formed in aqueous solutions upon electrostatic binding of 
block ionomer with oppositely charged molecules. The resulting complexes represent micelle-like 
particles termed “polyion complex micelles”[5-7], or “block ionomer complexes” (BICs) [8,9]. They  
have attracted great attention in various applications for delivery of low molecular mass drugs [10-13], 
proteins [14,15], polynucleotides (antisense oligonucleotides [16,17], plasmid DNA [18,19], siRNA 
[20,21]) and imaging agents [22,23]. For example, due to extended blood circulation and ability to 
circumvent renal excretion, known as the “enhanced permeability and retention (EPR) effect” 
[24,25], BICs loaded with anticancer drugs exhibit preferential accumulation and delivery of their 
cargos to solid tumors [26]. 
A special class of BICs was previously prepared by reacting block ionomers with surfactants of 
opposite charge, resulting in the spontaneous formation of the nanomaterials, which differ in sizes and 
morphologies, such as micelles and vesicles [27-34]. These materials contain a hydrophobic core formed 
by the surfactant tail groups and a hydrophilic shell formed by nonionic chains of the block copolymer (for 
example by PEG). These BICs can incorporate charged surfactant drugs, such as retinoic acid that binds to 
the polyelectrolyte chains, as well as hydrophobic non-charged drugs that solubilize in the hydrophobic 
domains formed by surfactant tail groups [35]. They display an ability to respond to the changes in the 
environmental parameters such as pH and ionic strength and can be designed to release drugs triggered by 
the environment in the target cell [36]. The simplicity of design and availability of diverse surfactant 
components for preparation of such BICs makes them quite attractive for development of carriers for drug 
delivery. 
Here we explore BICs formed by anionic poly(ethylene 
glycol)-block-poly(4-vinylbenzylphosphonate) block ionomer (PEG-b-PVBP) and cationic surfactants 
(Scheme 1). The structure of PEG-b-PVBP is quite different compared to regular “double 
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hydrophilic” block ionomers, such as PEG-block-poly(methacrylic acid) (PEG-b-PMA), that were 
previously studied by us and others [37,38]. Specifically, the polyion segment of PEG-b-PVBP 
contains hydrophobic styrene moiety in every repeating unit, which can strongly affect the 
self-assembly and colloidal stability of the resulting BICs. Furthermore, in addition to a regular 
cationic surfactant we explored the use of a cationic surfactant drug, doxorubicin (DOX) for 
preparation of BICs. Since such BICs are potential drug delivery vehicles their loading efficacy 
with respect to DOX, the release rate of DOX at different environmental pH and in vitro 
cytotoxicity in cancer cells were also examined. Overall the results of this study further advance the 
potential use of BICs in drug delivery. 
 
 
Scheme 1. Schematic illustration of self-assembly of the block ionomer complexes. 
 
MATERIALS AND METHODS 
Materials 
PEG-b-PVBP block copolymer was synthesized as described in our previous report [39]. 
The repeating units for PEG and PVBP blocks were 113 and 20, respectively. Methanol, 
dodecyltrimethylammonium bromide (DTAB), hexadecyltrimethylammonium bromide (HTAB), 
and cetylpyridinium chloride (C16Py) were purchased from Sigma-Aldrich (St Louis, MO). 
Dodecylpyridinium chloride (C12Py) was purchased from Tokyo Chemical Industry, Co., Ltd, 
(Tokyo, Japan). Doxorubicin hydrochloride (DOX) was kindly provided by Dong-A Pharmaceutical 
Company (Korea). Lysotracker Green, fetal bovine serum (FBS), and Dulbecco’s Modified Eagle’s 
Medium (DMEM) were purchased from Invitrogen Inc (Carlsbad, CA). MTT reagent 
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) was purchased from Research 
Products International (Mount Prospect, IL). All other chemicals were used without further 
purification. 
 
Preparation of BICs formed by PEG-b-PVBP and cationic surfactants 
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Cationic surfactants (DTAB, HTAB, C12Py, and C16Py) and PEG-b-PVBP were 
separately dissolved in water and methanol, respectively. Their concentrations were 50 mM and 22 
mM, respectively. An aqueous solution surfactant and water were added to a vial followed by 
addition of 0.2 mL of PEG-b-PVBP solution in methanol to achieve the desired composition of the 
mixture. Final volume of the solution was adjusted to 2.4 mL with water. Methanol was removed by 
evaporation. The composition of the mixture (Z value) was expressed as the molar ratio of the 
concentration of the surfactant to the concentration of 4-vinylbenzylphosphonate (VBP) units, Z = 
[surfactant]/[VBP]. For example, when the 0.088 mL of surfactant solution was mixed with 0.2 mL 
of PEG-b-PVBP solution, the Z value of the mixture was 1.0. Surfactant composition of the BIC is 
labeled in accordance with the surfactant nomenclature, i.e. DTAB/PEG-b-PVBP refers to the BIC 
formed from DTAB surfactant and copolymer. 
 
Fluorescence measurements 
Fluorescence spectra and intensity measurements were carried out using Fluorolog3 
(Horiba Jobin Yvon, France). Pyrene solubilization method was used to detect the onset of 
surfactant aggregation [40,41]. The known amounts of pyrene in acetone were added to empty vials, 
followed by acetone evaporation. Solutions of surfactants or surfactant/PEG-b-PVBP mixture in 
phosphate buffer (10 mM, pH7.0) containing 5 vol% of methanol were added to the vials and kept 
overnight under constant stirring at room temperature. Pyrene concentration in the final solution 
was 0.95 µM. Pyrene fluorescence spectra were recorded at λex = 336 nm, λem = 340 – 460 nm, and 
bandwidth of 2.5 nm for excitation and emission. All measurements were performed at room 
temperature. 
 
Size and ζ-potential measurements 
Effective mobility and z-averaged hydrodynamic diameters of the BICs were determined 
by dynamic light scattering (DLS) using ZetasizerNano ZS (Malvern Instruments, U.K.) equipped 
with a He-Ne laser that operated at a wavelength of 635 nm. Measurements were performed at a 
detection angle of 173º	 at room temperature. ζ-potential of the particles was calculated from the 
electrophoretic mobility value using Smoluchowski equation. Software provided by the 
manufacturer which employs cumulants analysis and non-negatively constrained least-squares 
particle size distribution analysis routines was used to analyze the size of the particles, 
polydispersity indices (PDI), and ζ-potential. The mean values were calculated from the 
measurements performed at least in triplicate. 
 
Atomic Force Microscopy (AFM) measurements 
AFM imaging was performed in air using a Multimode NanoScope IV system (Veeco, 
Santa Barbara, CA) operating in a tapping mode. The unbound surfactant and large aggregates were 
separated from the BICs solutions using NAP column (GE Healthcare, US) and 0.22 µm filter 
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purification before AFM measurement. The samples were prepared by depositing 5 µL of BICs 
solutions onto positively charged 1-(3-aminopropyl)silatrane mica surface (APS mica) for 2 min 
followed by drying the surface under argon atmosphere. The imaging was performed with regular 
etched silicon probes (TESP) with a spring constant of 42 N/m. The images were processed and the 
widths and heights of the particles were measured using FemtoScan software (Advanced 
Technologies Center, Moscow, Russia). 
 
Preparation of DOX and PEG-b-PVBP complex 
DOX/PEG-b-PVBP BICs were prepared using a procedure similar to the one described 
above for surfactant/PEG-b-PVBP. Briefly, 0.2 mL of PEG-b-PVBP solution in methanol was 
added to aqueous solution of DOX, and final volume of the mixture was adjusted to 2.4 mL with 
water. Methanol was removed by evaporation. The composition of the mixture was expressed as the 
molar ratio of the DOX concentration to the concentration of VBP units, Z = [DOX]/[VBP]. The 
unbound DOX was removed by ultrafiltration using Amicon Ultra-4 centrifugal filter devices 
(MWCO 10000 Da, Millipore) pretreated with DOX. The final concentration of DOX in the BIC 
dispersions was determined by measuring the absorbance at 485 nm using Lambda 25 UV/VIS 
spectrophotometer. 
 
Release studies of DOX 
Release of DOX from the DOX/PEG-b-PVBP BICs was examined in acetate buffer saline 
(ABS) (pH5.5, 145 mM NaCl), phosphate buffer saline (PBS) (pH7.4, 145 mM NaCl), and DMEM 
media (pH7.4, 145 mM NaCl, 10 % FBS) at 37 ºC by dialysis method using a membrane (MWCO 
3,500 Da). At definite time intervals (1 – 48 h), 1 mL samples of the dialysate solution were 
withdrawn and replaced with an equal volume of fresh media. The concentration of DOX in 
dialysate samples was determined spectrophotometrically by measuring absorbance at 485 nm. The 
amount of DOX released from the BICs was expressed as a percentage of the total DOX and plotted 
as a function of time. 
 
In vitro cytotoxicity studies 
Cytotoxicity of DOX/PEG-b-PVBP BIC was assessed human breast cancer cell line 
MCF-7 by a standard MTT assay. Briefly, cells were seeded in a 96-well microtiter plates with 
5000 cells per well and allowed to adhere for 24 h prior to the assay. Cells were exposed to various 
doses (0 – 200 µg/mL on DOX basis) of DOX alone, PEG-b-PVBP micelles alone, and 
DOX/PEG-b-PVBP BIC for 24 h at 37 ºC, followed by washing with PBS, and maintaining in 
RPMI 1640 medium with 10 % FBS for additional 72 h. The 25µL of MTT indicator dye (5 
mg/mL) was added to each well and the cells were incubated for 2 h at 37 ºC in the dark. The 100 
µL of 50 % DMF-20% SDS solution was added to each well and kept overnight at 37 ºC. 
Absorption was measured at 570 nm in a microplate reader (SpectraMax M5, Molecular Devices 
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Co., US) using wells without cells as blanks. All measurements were taken eight times. 
 
Confocal microscopy on live cell 
Cellular uptake of DOX/PEG-b-PVBP BIC was characterized by live cell confocal 
imaging using Carl Zeiss LSM 510 Meta Confocal microscope (Peabody, MA). MCF-7 cells were 
plated in live cell chambers (Fischer Scientific, Waltham, MA) and after two days (37 ºC, 5 % CO2) 
exposed to DOX/PEG-b-PVBP BIC for 30 min, followed by incubation with Lysotracker Green for 
5 min. Finally, cells were washed and kept in complete media for confocal imaging. 
 
RESULTS AND DISCUSSION 
Formation of BIC as a function of surfactant concentrations 
The interaction between PEG-b-PVBP and various cationic surfactants was characterized 
by steady-state fluorescence using pyrene as a probe. The ratio of intensities of the first and third 
highest energy emission peaks in the pyrene spectrum (I1/I3 ratio) correlates with the polarity of the 
immediate environment of the pyrene probe. In aqueous solution the I1/I3 ratio is about 1.7-1.9 
while in a nonpolar solvent such as hexane it is about 0.6 [41]. In a typical surfactant solution below 
the critical micelle concentration (cmc) the I1/I3 value is the same as that in water. When the 
concentration of surfactant exceeds the cmc, the I1/I3 ratio drops significantly, indicating the 
incorporation of pyrene into the nonpolar interior of the micelle. 
 
 
 
Association behavior of PEG-b-PVBP copolymer was examined using fluorescence 
measurements. The I1/I3 fluorescence intensity ratio of pyrene in PEG-b-PVBP solution depended 
on the copolymer concentration (Supplementary Information, Figure S1). Due to the presence of 
methanol in the sample solutions (5 vol%), the environment of pyrene probe was less polar than in 
the pure water and was characterized by the I1/I3 ratio 1.53 even in the absence PEG-b-PVBP 
copolymer. As the concentration of PEG-b-PVBP increased this copolymer alone formed micelles 
with the cmc value of 4.4 ×10-5 M (0.4 mg/mL), which was determined by the onset of sharp 
decrease of I1/I3 ratio value. 
The interaction between polyions and oppositely charged surfactants is a cooperative 
process in which the surfactant ionic head groups bind to the polyion units while the surfactant alkyl 
tails segregate into a hydrophobic microphase. This process is characterized by “critical association 
concentration” (cac), corresponding to the onset of surfactant binding to the polymer. As seen in 
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Figure S2 in Supplementary Information for various surfactant/PEG-b-PVBP mixtures the I1/I3 ratio 
remained practically constant or only slightly changed below the cac. Above the cac the I1/I3 
decreased significantly reflecting the partitioning of the pyrene into the hydrophobic environment 
formed by the surfactant alkyl groups. The dependencies of the I1/I3 ratio vs. concentration for each 
surfactant in the polymer-free systems are also presented in Figure S2 in Supplementary 
Information for comparison. For all surfactants studied the cac values determined in the presence of 
PEG-b-PVBP copolymer were about one order of magnitude lower than the corresponding cmc 
(Table 1). This suggested that PEG-b-PVBP enhanced the surfactant aggregation as a result of 
electrostatic coupling of the surfactant head groups and polyion repeating units. 
 
Characterization of BICs 
The surfactant/PEG-b-PVBP BICs were characterized on a macroscopic level by photon 
correlation spectroscopy and laser microelectrophoresis technique at various compositions of the 
mixture. Figure 1 presents averaged particle size, polydispersity, and ζ-potential of BICs as a 
function of Z at various pH values. Notably, no precipitation in BIC dispersions was observed over 
the entire range of the studied compositions of the mixture. In all cases, hydrodynamic diameters 
and polydispersity of BIC particles were about 50 nm and 0.3, respectively. These values remained 
practically constant upon variations of the composition of the mixture (0.5 ≤ Z ≤ 2.0) and pH from 
5.0 to 8.0. Steric repulsion of the PEG chains prevents the BICs from secondary agglomeration, 
retaining the high solubility of the BICs in aqueous solutions 
It is also important to note that there were little if any differences in ζ-values for all BICs at 
different pH, from pH5.0 to pH8.0 (Figure 1 (c)). In all cases, ζ-values were negative at Z < 1. 
Therefore, only a part of PVBP chain was neutralized by the surfactant under these conditions, 
while the remaining ionized phosphonate groups provided for the net negative charge of the 
particles. As Z value increased the value of ζ-potential is also increased due to progressive 
neutralization of PVBP units by surfactant cations. Notably, in the case of cationic surfactants 
having relatively long alkyl chains (HTAB and C16Py), ζ-potential reached 0 in the vicinity of Z = 
1 suggesting that practically all surfactant ions present in the system formed salt bonds with 
phosphonate groups of PEG-b-PVBP. At Z > 1, the particles of BIC formed in 
HTAB/PEG-b-PVBP and C16Py/PEG-b-PVBP mixtures became positively charged. The change in 
the sign of the ζ-potential indicated the incorporation of an excess of surfactant into the BIC 
particles. Indeed, the fraction of unbound C16Py in the solution was practically constant in the 
entire range of the compositions of mixture studied (Supplementary Information, Figure S3). It is 
likely that the aliphatic tails of the surfactant inserted into the hydrophobic domains of the BIC 
while the ionic head groups were exposed to water. Similar behavior was previously described for 
regular BIC of various block copolymers and oppositely charged surfactants [9,42]. However, the 
less hydrophobic surfactants with shorter aliphatic groups (DTAB and C12Py) exhibited reduced 
ability for incorporation into the BICs at the surfactant excess. In these cases the net charge of the 
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particles leveled-off close to zero only in the vicinity of Z = 2.0. No inversion of the charge was 
observed for DTAB/PEG-b-PVBP and C12Py/PEG-b-PVBP mixtures at the excess of added 
surfactant. Furthermore, the fraction of unbound surfactant (C12Py) increased as Z value increased 
(Supplementary Information, Figure S3)	 suggesting that the excess of surfactant did not 
incorporate into the complex and coexisted with the BICs in dispersion.  
We performed the further characterization of surfactant/PEG-b-PVBP BICs by using 
electrostatically neutralized BICs. At Z value was around 1.0, ζ-potential values of various 
surfactant/PEG-b-PVBP BICs were reached to around 0 mV (Figure 1 (c)). Thus, we have focused 
on the Z = 1.0 for further characterization of surfactant/PEG-b-PVBP BICs. The size and shape of 
the BICs were further characterized by the tapping-mode AFM. The typical images of BICs formed 
by PEG-b-PVBP and cationic surfactants (HTAB and C16Py) showed round nanoparticles (Figure 
2). The number-average particle diameters of 30.20 ± 3.56 nm and 33.35 ± 5.08 nm were 
determined for HTAB/PEG-b-PVBP and C16Py/PEG-b-PVBP BICs deposited on mica, 
respectively. It is reported that micelle size and its distribution tend to decrease during drying 
process [38]. Thus, smaller size and size distribution of BICs in AFM analysis are probably due to 
drying process on mica. 
 
 
Figure 1. Average hydrodynamic diameter (a), PDI (b), and ζ-potential (c) of BICs at various pH 
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and compositions of the mixture, Z: pH5.0 (open triangles), pH7.0 (filled circles), and pH8.0 (open 
squares). The data presented as mean ± SD (n = 5). 
 
 
Figure 2. Tapping mode AFM images in air of (a) HTAB/PEG-b-PVBP BIC and (b) 
C16Py/PEG-b-PVBP BIC. Composition of the surfactant/PEG-b-PVBP was Z = 1.0, pH7.0. 
 
Effect of salt concentration on BICs 
Addition of low molecular weight of salts to complexes of electrolytes with oppositely 
charged surfactants usually leads to destabilization of the salt bonds. Figure 3 presents the DLS 
graphs of the particles size distribution of various BICs (Z = 1.0) at different concentrations of the 
added NaCl. PEG-b-PVBP micelles alone displayed formation of large aggregates at the 
physiological concentration of the salt, which was further enhanced as the salt concentrations 
increase. In this case it was possible that the sodium counter ions screened the phosphonate groups 
of PVBP chains and decreased their electrostatic repulsion, thus favoring increased aggregation of 
PEG-b-PVBP at the higher ionic strength. On the other hand, addition of salt could have decreased 
the quality of water as a solvent for PEG, thus, decreased PEG steric stabilizing capacity, also 
favoring formation of large aggregates. Similarly, formation of larger aggregates and increases in 
particle polydispersity observed in DTAB/PEG-b-PVBP BICs, albeit at much higher concentrations 
of added salt (around 0.66 M). Such behavior was not seen for the C12Py/PEG-b-PVBP BICs, 
which displayed practically same sizes and polydispersity values in the entire range of salt 
concentrations studied. At the same time, the amount of the unbound C12Py surfactant was 
increased nearly 2-fold in 0.15 M solution of NaCl compared to C16Py surfactant (Supplementary 
Information, Figure S4). Upon further increase in salt concentration up to 1 M there was no 
additional release of surfactant ions from the BICs. Based on the observed differences in behavior 
of DTAB/PEG-b-PVBP BICs and C12Py/PEG-b-PVBP BICs in response to added salt it seems 
reasonable to attribute a higher stability of BIC formed by C12Py surfactants to the additional 
hydrophobic interactions of the pyridinium moieties with benzyl groups in VBP units. In the case of 
BIC formed by surfactants with longer alkyl chains, no differences in particle size/polydispersity 
were observed for either HTAB/PEG-b-PVBP or C16Py/PEG-b-PVBP BICs (Figure 3). In addition, 
the fraction of unbound C16Py in the solution did not change in the entire range of the salt 
concentration (Supplementary Information, Figure S4). Altogether, the effects of added salt 
suggested that the stability of BICs formed in the surfactant/PEG-b-PVBP mixtures depended on 
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the structure of ionic head group and alkyl tails of the surfactant. The surfactants with either 1) 
longer alkyl tail or 2) aromatic head group formed the more stable complex. 
 
 
Figure 3. Dependence of particle size distribution of BICs on the concentration of NaCl. 
Composition of the surfactant/PEG-b-PVBP mixture was Z = 1.0, the concentration of 
PEG-b-PVBP was 1.83 mmol/L, pH7.0, r.t.. 
 
Preparation of DOX and PEG-b-PVBP complex 
We evaluated a possibility to immobilize a cationic anti-cancer drug (DOX, pKa = 8.2) 
into BICs based on PEG-b-PVBP. The complexes were prepared by mixing the aqueous solution of 
DOX and methanol solution of block copolymer at pH7.0. The average hydrodynamic diameter and 
ζ-potential of the complexes obtained at various compositions of the mixtures are presented in 
Figure 4. Similarly to the surfactant/PEG-b-PVBP BIC, the average hydrodynamic diameters and 
polydispersity of DOX/PEG-b-PVBP BIC remained practically constant (ca. 50 nm and 0.25, 
respectively) upon variations of the composition of the mixture (0.1 ≤ Z ≤ 1.0) (Figure 4(a)). At Z < 
1 ζ-potential of the BICs was increases as the concentration of the added DOX (Figure 4(b)). Nearly 
all added DOX molecules were incorporated into BIC since practically no unbound DOX was 
detected in the solution at 0.1 ≤ Z ≤ 1.0 (Supplementary Information, Figure S5).  
We performed the further characterization of DOX/PEG-b-PVBP BICs by using 
electrostatically neutralized BICs. At Z ≥ 0.5, ζ-potential value of DOX/PEG-b-PVBP BICs was 
around 0 mV (Figure 4 (b)). Thus, we have focused on the Z = 0.5 for further characterization of 
DOX/PEG-b-PVBP BICs. The binding of DOX with PEG-b-PVBP was also supported by 
quenching of DOX fluorescence (by ca. 80 %) compared to the fluorescence of free DOX in an 
aqueous solution (Figure 4(c)). Substantial reduction in DOX fluorescence intensity can be 
attributed to the self-association of DOX molecules bound to the PVBP chains within the core of 
complexes. Overall, total drug loading of about 35.7 % wt. was obtained (expressed as mass of 
incorporated DOX per mass of DOX/PEG-b-PVBP mixtures). AFM suggested that BICs particles 
formed in these mixtures appeared to be spherical with a number-averaged height of 2.17 ± 0.41 nm 
and diameter of 42.31 ± 2.38 nm (Figure 4(d)). 
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Figure 4. Average hydrodynamic diameter (filled circles) and PDI (open squares) (a) and ζ-potential 
(b) of DOX/PEG-b-PVBP BIC. The data presented as mean ± SD (n = 5). (c) Fluorescence 
emission spectra of free DOX (1), DOX/PEG-b-PVBP BIC (2), and PEG-b-PVBP alone (3). (d) 
Tapping mode AFM image in air of DOX/PEG-b-PVBP BIC. Composition of the 
DOX/PEG-b-PVBP mixture was Z = 0.5, pH7.0, r.t.. 
 
Salt and serum stability of DOX/PEG-b-PVBP BICs 
Figure 5(a) presents the dependence of particle size and polydispersity of 
DOX/PEG-b-PVBP BIC (Z = 0.5) on the concentration of NaCl. The averaged diameter and 
polydispersity of these BICs did not change in the entire range of the salt concentrations studied (up 
to 1 M). In addition, DOX/PEG-b-PVBP BICs showed very little if any release of DOX: less than 
2 % of unbound DOX was detected in the BIC dispersions at high salt concentrations 
(Supplementary Information, Figure S6). These data suggested that DOX/PEG-b-PVBP BICs were 
remarkably stable. In comparison, BICs formed in DOX/PEG-b-poly(methacrylic acid) mixture 
displayed progressive disintegration in the presence of salt followed by their complete 
disappearance at 0.13 M NaCl.35) Furthermore, DOX/PEG-b-PVBP BICs were stable in the 
presence of 10 % FBS in the buffer (Figure 5(b)) and no changes in particle size and polydispersity 
of these BICs were determined for at least a week. As in the case of surfactant/PEG-b-PVBP BICs, 
such high stability of DOX/PEG-b-PVBP BIC in both salt and serum solution was probably due to 
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that the core of DOX/PEG-b-PVBP BIC was stabilized by both electrostatic and hydrophobic 
interactions. 
 
 
Figure 5. (a) Dependence of average particle size (filled circles) and PDI (open squares) of 
DOX/PEG-b-PVBP BIC on the concentration of NaCl. (b) Time dependence of the average particle 
size (filled circles) and PDI (open squares) of DOX/PEG-b-PVBP BIC in 10 % FBS solution (10 
mM phosphate buffer, pH7.4, 150 mM NaCl, 10 % FBS). Composition of the DOX/PEG-b-PVBP 
was Z = 0.5, pH7.0, r.t.. 
 
 
Figure 6. Time- and pH-dependent DOX release profiles of the DOX/PEG-b-PVBP BIC in (filled 
squares) ABS (pH5.5), (open circles) PBS (pH7.4), and (filled triangles) DMEM (pH7.4, 10 % 
FBS). The data presented are mean ± SD (n = 3). Composition of the DOX/PEG-b-PVBP mixture 
was Z = 0.5. 
 
Release of DOX from BIC 
The DOX release from the DOX/PEG-b-PVBP BIC was pH-dependent with the rate of the 
release being much faster at acidic pH5.5 than at neutral pH7.4 (Figure 6). At pH7.4 there was a 
small initial burst release of DOX (ca. 15 %) from DOX/PEG-b-PVBP BIC followed by slow and 
practically linear release of nearly 40 % of the drug over 50 h. Furthermore the release profile at neutral 
pH did not seem to be affected by the presence of the serum. In contrast at pH5.5 nearly 45 % of DOX 
was released during first 8 h. Such release profile at lower pH is noteworthy considering that the pH 
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in the endosomes and lysosomes are in the range of pH5 to pH6. The pKa value of PEG-b-PVBP is 
both pKa1 = 2.1 and pKa2 = 7.2, respectively. At the neutral conditions, about 25 % of phosphonate 
groups were protonated. On the other hand, at the acidic pH conditions (pH5-6), about 45 – 55 % of 
phosphonate groups were protonated. Therefore, the accelerated DOX release from 
DOX/PEG-b-PVBP BIC at the acidic pH was probably due to the protonation of phosphonate 
groups of PVBP chains in the DOX/PEG-b-PVBP BICs. 
 
 
Figure 7. In vitro cytotoxicity of DOX/PEG-b-PVBP BIC against MCF-7 cells. (Filled circles) 
PEG-b-PVBP alone, (filled squares) DOX/PEG-b-PVBP BIC, and (open squares) free DOX. 
Composition of the DOX/PEG-b-PVBP mixture was Z = 0.5, pH7.0. The data presented as mean ± 
SD. 
 
 
Figure 8. Fluorescence microscope images of the MCF-7 cells incubated with DOX/PEG-b-PVBP 
BIC. (a) DOX, (b) Late endosome or lysosome, (c) DIC, and (d) merged image. Composition of the 
DOX/PEG-b-PVBP mixture was Z = 0.5, pH7.0. 
 
In Vitro Cytotoxicity and Intracellular Delivery 
Cytotoxic activity of DOX/PEG-b-PVBP BIC was assessed against human MCF-7 breast 
cancer cells (Figure 7). The cell viability was progressively reduced as the concentration of free 
DOX or DOX/PEG-b-PVBP BIC increased. However, DOX incorporated into the complexes 
displayed lower cytotoxic effect on the cancer cells than the free DOX. Importantly, it was found 
that PEG-b-PVBP alone was not toxic in the entire range of concentrations used for the treatment 
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with DOX/PEG-b-PVBP complex formulation.  
Furthermore, cellular uptake of the DOX/PEG-b-PVBP BIC was characterized by live cell 
confocal imaging. In the case of free DOX, an increase in nuclear fluorescence intensity in the 
MCF-7 cells was observed for 30 min incubation as shown in Figure S7 in Supplementary 
Information, indicating the binding of DOX to the nuclear DNA. The DOX/PEG-b-PVBP BIC was 
also readily internalized into MCF-7 cells after 30 min incubation (Figure 8). However, significant 
co-localization of DOX/PEG-b-PVBP BIC with Lysotracker Green, a marker of late endosome and 
lysosome, was observed (Figure 8(d)) in this case. This result indicated that DOX/PEG-b-PVBP 
BIC was probably taken up by MCF-7 cells via the endocytic pathway and retained in the late 
endosome or lysosome. In acidic compartment such as lysosome, the release of DOX was 
accelerated with time due to the protonation of phosphonate groups of PVBP chains. 
 
CONCLUSIONS 
BICs formed by PEG-b-PVBP and several cationic surfactants were successfully prepared. 
These complexes spontaneously self-assemble in aqueous solutions into particles with average size of 
40 - 60 nm. The size and ζ-potential of these complexes were not affected by variation in pH. The cac 
value was about 1 order of magnitude lower than the cmc. Furthermore, the stability of such complexes 
was not affected by added salt up to 1 M concentration. Because of PEG-b-PVBP possess hydrophobic 
styrene moieties, the formed complexes were stabilized by not only electrostatic but also by 
hydrophobic interactions. Moreover, PEG-b-PVBP was used for immobilization and drug delivery of 
DOX. The DOX/PEG-b-PVBP BIC also displayed high stability against dilution, changes in ionic 
strength. The DOX/PEG-b-PVBP BIC showed almost no initial burst release of the DOX under 
physiological extracellular pH, albeit whereas significant release of DOX from DOX/PEG-b-PVBP 
BIC was observed at the acidic pH mimicking the endosomal/lysosomal environment. The cytotoxic 
activity of the DOX/PEG-b-PVBP BIC against the MCF-7 cancer cells was lower than that of the 
free DOX, which was consistent with the sustained release of DOX from the complexes. 
DOX/PEG-b-PVBP BIC was readily internalized into MCF-7 cells after 30 min incubation. 
Furthermore, co-localization of DOX/PEG-b-PVBP BIC with Lysotracker was observed in MCF-7 
cells, which indicated that DOX/PEG-b-PVBP BIC reached late endosome or lysosome. From these 
findings, the obtained complexes are promising as novel nanocarriers for drug delivery. 
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